Park Medi World IPO Details
The key details of Park Medi World’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.
| IPO Size | ₹920.00 Cr |
| Price Range | ₹154 - ₹162 |
| Retail Quota | 35% |
| QIB Quota | 50% |
| NII Quota | 15% |
| Employee Discount | -- |
| Listing at | NSE and BSE |
| Minimum Quantity | 92 |
| Investment (cut-off price) | ₹14,904 |
| Pre IPO Promotor Holding | 95.55% |
| Post IPO Promotor Holding | 82.89% |
| DHRP Draft | Click Here |
| RHP Draft | Click Here |
| Anchor Investors List | Click Here |
Park Medi World IPO Timelines
The IPO process for Park Medi World includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.
10/12/2025
Start Date12/12/2025
End Date16/12/2025
Refund Initiation16/12/2025
Credit of Shares to Demat Ac17/12/2025
Listing DatePark Medi World IPO Lot Size
The Park Medi World IPO has a fixed lot size of 92 shares, at an upper price band of ₹162 per share. For retail investors, the minimum application is 92 shares (1 lot) amounting to ₹14,904, while the maximum is 1,196 shares (13 lots) worth ₹1,93,752. For Small HNI (S-HNI) investors, the minimum application is 1,288 shares (14 lots) worth ₹2,08,656, while the maximum is 6,164 shares (67 lots) amounting to ₹9,98,568. Big HNI (B-HNI) investors need to apply for at least 6,256 shares (68 lots), totaling ₹10,13,472.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 92 | ₹14,904 |
| Retail Maximum | 13 | 1196 | ₹1,93,752 |
| S-HNI Minimum | 14 | 1288 | ₹2,08,656 |
| S-HNI Maximum | 67 | 6164 | ₹9,98,568 |
| B-HNI Minimum | 68 | 6256 | ₹10,13,472 |
Park Medi World IPO Subscription Status
The subscription status for Park Medi World IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.
| QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|
| 12.07x | 15.93x | 3.32x | -- | 8.52x |
IPO Performance on Listing Day
| Opening Price | Closing Price | Day High | Day Low |
|---|---|---|---|
| ₹ | ₹ | ₹ | ₹ |
Park Medi World IPO Company Financials
Park Medi World reports robust performance in FY2026 September with Total Income of ₹823.39 crores, managing expenses at ₹649.50 crores, and achieving a strong PAT (Profit After Tax) of ₹139.14 crores, demonstrating significant growth potential ahead of its public offering.
| Year | Total Income | Total Expense | PAT |
|---|---|---|---|
| FY 2023 | ₹1,272.18 | ₹955.37 | ₹228.19 |
| FY 2024 | ₹1,263.08 | ₹1,041.66 | ₹152.01 |
| FY 2025 | ₹1,425.97 | ₹1,139.30 | ₹213.22 |
| FY 2026 (6 M) | ₹823.39 | ₹649.50 | ₹139.14 |
About Company
Park Medi World Limited, incorporated in 2011, is a private hospital chain operating mainly in North India with a total capacity of 3,000 beds as of March 31, 2025. It runs 14 multi super speciality hospitals under the Park brand, all accredited by the National Accreditation Board for Hospitals and Healthcare Providers, with eight also accredited by the National Accreditation Board for Testing and Calibration Laboratories. The network spans Haryana, Delhi, Punjab and Rajasthan, offering more than 30 super speciality and speciality services including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics and oncology.
As of September 30, 2025, the hospitals collectively featured 870 ICU beds, 67 operating theatres and an oxygen generation plant at every location. The chain operates facilities in cities such as Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat and Faridabad in Haryana, as well as Delhi, Patiala and Mohali in Punjab and Jaipur and Behror in Rajasthan. Park Medi World Limited employed 1,014 doctors and 2,142 nurses, supporting its extensive clinical operations.
| Incorporation Date | Sector | Managing Director |
|---|---|---|
| 2011 | Healthcare | Ankit Gupta |
Know Before Investing
Park Medi World IPO Strengths
- Park Medi World operates one of the larger private hospital chains in North India with around 3,000 beds across multiple facilities as of March 31, 2025, giving it meaningful regional scale and brand recall.
- The network provides multi-specialty services including critical care, robotic surgery, oncology, trauma, cardiac, neuro and mother-and-child care, helping drive higher ARPOB and case-mix diversification.
- The company has acquired and integrated seven hospitals across locations such as Faridabad, Karnal, Ambala, Behror, Palam Vihar, Sonipat and Mohali, demonstrating M&A execution capability.
- Rising healthcare awareness, ageing demographics, increasing insurance penetration and under-served tier‑2/3 markets in North India provide secular growth tailwinds.
Park Medi World IPO Risks
- Operations are largely concentrated in North India; region-specific economic, regulatory or competitive disruptions could materially impact performance.
- Returns from the planned new Park Medicity (NCR) project and Blue Heavens expansion depend on timely completion, regulatory approvals, clinician ramp-up and occupancy improvement.
- Private hospitals are exposed to evolving regulations on pricing (especially for stents, implants, consumables), clinical norms and insurance empanelment that may cap margins.
- Ability to attract and retain specialists, surgeons and senior clinicians is critical; attrition or competition for talent can affect service quality and patient inflows.
- Faces competition from well-capitalized national and regional hospital chains in NCR and Punjab – Haryana belt, which may pressure pricing and doctor retention.
- Past and future acquisitions require continuous integration of systems, culture and processes; any missteps could dilute margins and brand reputation.
Swot Analysis for Park Medi World IPO
Strengths
Regional Scale Leadership, Comprehensive Clinical Offering, Accreditations & Quality
Weaknesses
Geographic Concentration, Rating Downgrade History, Capex & Execution Risk
Opportunities
Underserved Healthcare Demand, Government & Insurance Schemes, Digital & Outreach Programs
Threats
Regulatory & Pricing Pressure, Talent Retention Challenges, Macroeconomic & Policy Shifts
Company Details
Park Medi World Ltd.
12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, Delhi, New Delhi, 110018
Phone: + 91 124 696 000
Email: company.secretary@parkhospital.in
Website: http://www.parkhospital.in/
IPO Registar Details
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: parkmedi.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
FAQs
The key objectives of Park Medi World IPO are:
- Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries.
- Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively.
- Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri.
- Unidentified inorganic acquisitions and general corporate purposes.
Nuvama Wealth Management Limited, CLSA India Private Limited, DAM Capital Advisors Limited, Intensive Fiscal Services Private Limited are the book-running lead managers for the Park Medi World IPO.
Park Medi World IPO shows strong growth potential driven by plans to add 1650 beds by FY28 expanding total capacity to nearly 4900 beds while rising occupancy and higher complexity procedures enhance ARPOB. Its cluster based model in underserved regions supports scalable operations and long term healthcare demand expansion.
The issue price for the Park Medi World IPO is set between ₹154 to ₹162 per share.
To invest in one lot of Park Medi World IPO, you need ₹14,168 at the lower price band (₹154 per share) or ₹14,904 at the upper price band (₹162 per share) for a lot size of 92 shares.
Park Medi World IPO shares are scheduled to be listed on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on December 17, 2025.
Refund/unblocking of funds for Park Medi World IPO will begin on December 16, 2025. ASBA/UPI blocks will be removed within 1 working day.
You can sell shares your Park Medi World IPO shares on listing day (December 17, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.